Fibrosis markers. by Dwight D. Harris (14484648)

<i>RTTN</i>-mutated organoids exhibit decreased proliferation and increased cell death at early stages. by Justine Guguin (9088672)

Injection of dGAG-KI01 Decreases P. falciparum Sequestration of IE of Clinical Isolates in the Rat by Anna M Vogt (21629)

Hormone therapy decreased β-amyloid load and improved cognitive performance in early middle-aged mice. by Amy Christensen (4062937)

Fig 5 - by Duyan Geng (12072181)

In the absence of chloride, two-fold decrease in [Na⁺]_e shifted GLT-1a E_rev by −28 mV at both low and high glutamate concentrations. by Anatoli Y. Kabakov (729047)

“…Arrows show amplitudes and directions of E_rev shifts associated with decrease in [Na⁺]_e. <b>(D)</b> Average E_rev shifts at [Glu^-]_e geometric means of 37.5 and 600 μM are approximately equal when [Na⁺]_e was decreased from 102 to 51 mM. …”

Filamentation induced by DTPA is associated with a decrease in Nrg1 protein level, and requires the cAMP-PKA pathway and the kinase Sok1. by Elizabeth J. Polvi (3163500)

Local injection of p29 alleviates the reduction in myofiber size by restoration of the decreased numbers of satellite cells. by Yutaka Ohsawa (587120)

Everolimus decreased EC inflammation via lowered IL-1β and IL-6 expression in ECs. by Zsolt Fejes (844136)

PGRN deletion decreased the susceptibility to invasive <i>C</i>.<i>albicans</i> infection in mice. by Jiayu Liu (3951515)

Corneal nerves demonstrate delayed and decreased HSV-1 infection in conventional dendritic cell-depleted corneas. by Kai Hu (311882)

Loss of Runx1 in <i>mdx</i> mice decreases muscle mass, muscle strength and lifespan. by Kfir Baruch Umansky (783699)

HIF^C neutrophils have increased levels of apoptosis and necrosis and decreased endothelial attachment. by Kelly M. Shepardson (404375)

Longitudinal analysis of exploratory behavior during housing in Marlau™ cages is in favor of decreased anxiety in “enriched” rats. by Raafat P. Fares (288906)

Bee Venom for the Treatment of Parkinson Disease – A Randomized Controlled Clinical Trial by Andreas Hartmann (241073)

“…We conducted a prospective, randomized double-blind study in 40 Parkinson disease patients at Hoehn & Yahr stages 1.5 to 3 who were either assigned to monthly bee venom injections or equivalent volumes of saline (treatment/placebo group: n = 20/20). …”

Immunoblotting for TGF-beta, alpha-actinin, MMP-13, and mTOR. by Dwight D. Harris (14484648)

Immunoblotting for JAK, STAT, and SMAD. by Dwight D. Harris (14484648)

Intervention with MLKL decreased neutrophil death and protected mice against <i>E. coli</i> pneumonia. by Qinyu Luo (13000956)

Immunoblotting for insulin sensitivity markers. by Dwight D. Harris (14484648)

Immunoblotting FOXO1 and insulin receptors. by Dwight D. Harris (14484648)